Sai Life Sciences Limited (BOM:544306)
India · Delayed Price · Currency is INR 1,316.10
+1.65 (0.13%)
At close: Jul 31, 2026
Sai Life Sciences Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 278,953 | 205,849 | 158,581 | - | - | - | |
Market Cap Growth | 57.83% | 29.81% | - | - | - | - |
Enterprise Value | 280,259 | 206,963 | 166,413 | - | - | - |
Last Close Price | 1316.10 | 970.55 | 762.10 | - | - | - |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 79.95 | 59.00 | 93.21 | - | - | - |
PS Ratio | 12.72 | 9.39 | 9.36 | - | - | - |
PB Ratio | 11.23 | 8.29 | 7.45 | - | - | - |
P/TBV Ratio | 11.26 | 8.31 | 7.49 | - | - | - |
P/OCF Ratio | 54.79 | 40.43 | 50.50 | - | - | - |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 12.78 | 9.44 | 9.82 | - | - | - |
EV/EBITDA Ratio | 44.40 | 32.79 | 46.28 | - | - | - |
EV/EBIT Ratio | 60.36 | 44.58 | 61.49 | - | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 0.12 | 0.12 | 0.17 | 0.95 | 1.05 | 1.10 |
Debt / EBITDA Ratio | 0.46 | 0.46 | 0.88 | 3.28 | 5.80 | 8.18 |
Debt / FCF Ratio | - | - | - | 11.40 | 8.77 | - |
Net Debt / Equity Ratio | 0.05 | 0.05 | -0.01 | 0.76 | 0.82 | 0.85 |
Net Debt / EBITDA Ratio | 0.21 | 0.21 | -0.05 | 3.03 | 5.77 | 8.19 |
Net Debt / FCF Ratio | -1.56 | -1.56 | 0.36 | 9.13 | 6.85 | -7.35 |
Asset Turnover | 0.65 | 0.65 | 0.62 | 0.66 | 0.56 | 0.44 |
Inventory Turnover | 4.23 | 4.23 | 4.97 | 4.27 | 3.50 | 3.04 |
Quick Ratio | 0.64 | 0.64 | 1.58 | 1.05 | 0.93 | 0.99 |
Current Ratio | 1.69 | 1.69 | 2.05 | 1.28 | 1.27 | 1.32 |
Return on Equity (ROE) | 15.13% | 15.13% | 10.96% | 8.89% | 1.13% | 0.71% |
Return on Assets (ROA) | 8.55% | 8.55% | 6.22% | 4.83% | 1.90% | 0.98% |
Return on Invested Capital (ROIC) | 13.91% | 14.72% | 10.57% | 7.83% | 2.48% | 1.34% |
Return on Capital Employed (ROCE) | 16.60% | 16.60% | 11.10% | 11.20% | 4.60% | 2.10% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | 1.25% | 1.70% | 1.07% | - | - | - |
FCF Yield | -0.30% | -0.41% | -0.35% | - | - | - |
Buyback Yield / Dilution | -7.47% | -7.47% | -8.04% | -0.27% | -0.46% | -5.32% |